Abbott Laboratories (ABT)

R&D Expense Growth

16.67%

Quarterly · Period ending:

ABT logo

ABT R&D Expense Growth

Latest reported16.67%
ABT Quarterly R&D Growth (QoQ) (0.00% → 16.67%)
High-resolution chart · PNG

ABT r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Abbott Laboratories R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
16.6667%
2.8571%
-6.3694%
7.2404%
4.1252%
-3.4341%
2.1038%
2.2956%
2.0498%
-1.0145%
4.3873%
-6.9014%
8.5627%
-5.3546%
-11.4103%
14.0351%
-1.8651%
-8.0475%
12.7976%
2.7523%
0%
-6.3037%
20.3448%
2.8369%
-2.0833%
0.1739%
-3.1987%
2.9463%
-13.8806%
19.4296%
-2.0942%
0%
-1.3769%
-5.9871%
25.355%
-5.1923%
-3.8817%
60.0592%
0.5952%
-3.4483%
-8.1794%
2.71%
-2.381%
9.5652%
10.2236%
-13.2964%
17.5896%
-8.3582%
-13.4367%
0.2591%
8.1232%
-1.6529%
4.9133%
-69.6872%
-1.9389%
15.1335%
0.497%
-12.6438%
14.0205%
-2.6975%
11.6129%
-28.2204%
20.0771%
25.7576%
17.5342%
-2.282%
10.5101%
0.8955%
2.9592%
-11.0558%
7.5359%
3.5772%
5.953%
-6.4076%
3.3842%
9.8109%
0.8818%
-2.9846%
-3.4743%
-41.1414%
116.2948%
-1.0706%
9.2506%
0.811%
1.97%
-5.8864%
18.4502%
-10.266%
1.7449%
-11.6677%
10.6365%
8.9996%
-0.8064%
-6.1196%
10.0144%
3.5924%
6.3954%
-22.6901%
15.1783%
0.8116%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.